Mesenchymal Cell News Volume 7.10 | Mar 17 2015

    0
    16
    Mesenchymal Cell News 7.10 March 17, 2014

    Mesenchymal Cell News

         In this issue: Publications | Reviews | Industry News | Policy News | Events | Jobs
    Cell Therapy News on Facebook   MESCN on Twitter

     
    TOP STORY
    MitoCeption as a New Tool to Assess the Effects of Mesenchymal Stem/Stromal Cell Mitochondria on Cancer Cell Metabolism and Function
    Researchers showed that the transfer of minute amounts of mesenchymal stem/stromal cell mitochondria to cancer cells, a process otherwise occurring naturally in coculture, results in cancer cell enhanced oxidative phosphorylation activity and favors cancer cell proliferation and invasion. [Sci Rep] Full Article
    Request Your Free Wallchart: Mesenchymal Stem Cells (A Nature Reviews Molecular Cell Biology Collaboration)

     
    PUBLICATIONS (Ranked by impact factor of the journal)
    Combination of Electroacupuncture and Grafted Mesenchymal Stem Cells Overexpressing TrkC Improves Remyelination and Function in Demyelinated Spinal Cord of Rats
    Scientists attempted to graft neurotrophin-3 (NT-3) receptor (TrkC) gene modified mesenchymal stem cells (TrkC-MSCs) into the demyelinated spinal cord and investigated whether electroacupuncture treatment could promote NT-3 secretion in the demyelinated spinal cord as well as further enhance grafted TrkC-MSCs to differentiate into oligodendrocytes, remyelination and functional recovery. [Sci Rep] Full Article

    Diffuse and Persistent Blood-Spinal Cord Barrier Disruption after Contusive Spinal Cord Injury Rapidly Recovers following Intravenous Infusion of Bone Marrow Mesenchymal Stem Cells
    Researchers induced a contusive spinal cord injury at T9 in the rat and studied the effects of intravenous mesenchymal stem cells infusion on blood spinal cord barrier permeability, microvascular architecture and locomotor recovery over a ten week period. [Exp Neurol] Abstract

    Poly(γ-Glutamic Acid) as an Exogenous Promoter of Chondrogenic Differentiation of Human Mesenchymal Stem/Stromal Cells
    Poly(γ-glutamic acid)’s ability to support the production of cartilaginous extracellular matrix by human bone marrow mesenchymal stem/stromal cells and nasal chondrocytes was investigated. [Tissue Eng Part A] Abstract

    Compaction, Fusion, and Functional Activation of Three-Dimensional Human Mesenchymal Stem Cell Aggregate
    Researchers investigated the role of actin in regulating three-dimensional human mesenchymal stem cells (hMSCs) aggregate compaction, fusion, spreading and functional activation. They suggest that actin-mediated contractility influences hMSC aggregation, compaction, fusion, and spreading on adherent surface. [Tissue Eng Part A] Abstract

    The Therapeutic Effects of Human Mesenchymal Stem Cells Primed with Sphingosine-1 Phosphate on Pulmonary Artery Hypertension
    Scientists showed that priming human mesenchymal stem cells (MSCs) with sphingosine-1-phosphate (S1P) enhances their therapeutic efficacy in pulmonary artery hypertension. Human MSCs, similarly to hematopoietic stem cells, showed stronger chemoattraction to S1P in transwell assays. [Stem Cells Dev] Abstract

    Short-Term Memory of Danger Signals or Environmental Stimuli in Mesenchymal Stem Cells: Implications for Therapeutic Potential
    Scientists showed that, similar to immune cells, mesenchymal stem/stromal cells (MSCs) retain information from danger signals or environmental stimuli for a period of time. When treated with the pro-inflammatory factors lipopolysaccharide or tumor necrosis factor-α, MSCs display increased expression of IL-6, IL-8 and MCP-1. [Cell Mol Immunol] Abstract

    Examining the Feasibility of Clinical Grade CD271+ Enrichment of Mesenchymal Stromal Cells for Bone Regeneration
    Researchers assessed the feasibility of new clinical-grade technology to obtain uncultured mesenchymal stromal cell isolates from three human intra-osseous tissue sources based on immunomagnetic selection for CD271-positive cells. [PLoS One] Full Article

    Effect of Fatty Acids on Human Bone Marrow Mesenchymal Stem Cell Energy Metabolism and Survival
    Scientists report the first direct evidence that human bone marrow mesenchymal stem cell (BMMSC) energy metabolism is highly glycolytic with low rates of mitochondrial oxidative metabolism. The contribution of glycolysis to ATP production is greater than 97% in undifferentiated BMMSCs, while glucose and fatty acid oxidation combined only contribute 3% of ATP production. [PLoS One] Full Article

    Endoplasmic Reticulum Stress Participates in the Progress of Senescence of Bone Marrow-Derived Mesenchymal Stem Cells in Patients with Systemic Lupus Erythematosus
    Researchers investigated whether endoplasmic reticulum stress (ERS) would induce the senescence of bone marrow mesenchymal stem cells (BM-MSCs) from systemic lupus erythematosus (SLE) patients. They found that there was increased expression of glucose regulated protein 78 in BM-MSCs from SLE patients, which indicated the activation of ERS in BM-MSCs from SLE patients. [Cell Tissue Res] Abstract

    Pluronic F-127 Hydrogel as a Promising Scaffold for Encapsulation of Dental-Derived Mesenchymal Stem Cells
    Scientists tested the osteogenic and adipogenic differentiation capacity of dental pulp stem cells (DPSCs) in a thermoreversible Pluronic® F127 hydrogel scaffold encapsulation system in vitro. DPSCs were encapsulated in Pluronic® F-127 hydrogel and stem cell viability, proliferation and differentiation into adipogenic and osteogenic tissues were evaluated. [J Mater Sci Mater Med] Abstract

    Decreased Osteogenesis of Adult Mesenchymal Stem Cells by Reactive Oxygen Species under Cyclic Stretch: A Possible Mechanism of Age Related Osteoporosis
    Scientists compared the osteogenic potential of mesenchymal stem cells (MSCs) from young and adult rats under three rounds of two hours of cyclic stretch of 2.5% elongation at 1 Hz on three consecutive days. Cyclic stretch induced a significant osteogenic differentiation of MSCs from young rats, while a compromised osteogenesis in MSCs from the adult rats. [Bone Res] Full Article

    NEW MesenPureâ„¢ Highly Enriched Mouse MSC Cultures Without the Wait - FREE Sample Request

     
    REVIEWS
    Mesenchymal Stem Cell Exosomes
    The authors give a brief introduction of the biogenesis of MSC exosomes, review their physiological functions and highlight some of their biochemical potential to illustrate how MSC exosomes could restore tissue homeostasis leading to tissue recovery and repair. [Semin Cell Dev Biol] Abstract

    Visit our reviews page to see a complete list of reviews in the mesenchymal cell research field.

     
    INDUSTRY NEWS
    The Alliance for Regenerative Medicine Enters into Memorandum of Understanding with Japan’s Forum for Innovative Regenerative Medicine
    The Alliance for Regenerative Medicine announced it has entered into a memorandum of understanding with Japan’s Forum for Innovative Regenerative Medicine, effective immediately. [The Alliance for Regenerative Medicine] Press Release

    Cryoport Co-Sponsors the Alliance for Regenerative Medicine 3rd Annual REGENMED Investor Day
    Cryoport, Inc. announced that it is co-sponsoring the Alliance for Regenerative Medicine 3rd Annual REGENMED Investor Day, to be held March 25, 2015 at the Metropolitan Club in New York City. [Cryoport, Inc.] Press Release

    From our sponsor: Pluripotent cell isolation for regenerative medicine. Request a free wallchart from Nature.

     
    POLICY NEWS
    National Institutes of Health (United States)

    Food and Drug Administration (United States)

    Center for Biologics Evaluation and Research (United States)

    European Medicines Agency (European Union)

    Medicines and Healthcare Products Regulatory Agency (United Kingdom)

    Therapeutic Goods Administration (Australia)

     
    EVENTS
    NEW 2015 World Stem Cell Summit (WSCS15)
    December 10-12, 2015
    Atlanta, United States

    Visit our events page to see a complete list of events in the mesenchymal cell community.

     
    JOB OPPORTUNITIES
    NEW Postdoctoral Position – New Therapeutic Targets against Sarcoma Initiating Cells (The University Institute of Oncology of Asturias [IUOPA])

    Research Associate: Mesenchymal (STEMCELL Technologies Inc.)

    Scientist – Myogenic Progenitor Cell Biology (STEMCELL Technologies Inc.)

    Manufacturing Manager – Cell Therapy (Opexa Therapeutics)

    Postdoctoral Fellow/Research Associate – Leukemia, Stem Cells and Development (Josep Carreras Leukemia Research Institute)

    Postdoctoral Position – Pluripotent Stem Cells for Regenerative Medicine (Cells for Cells)

    PhD Positions – Cartilage Regeneration in Joints and Intervertebral Disc Diseases (University Medical Center Utrecht)

    Instructor – Regulation of Stem Cell Differentiation in Vascular Disease (The University of Alabama at Birmingham)

    Director – Vector Production (Sangamo BioSciences, Inc.)

    Senior Process Development Engineer (Sangamo BioSciences, Inc.)

    Postdoctoral Position – Morphogenetic Signaling Pathways in Development and Disease (University of Rochester Medical Center)


    Recruit Top Talent: Reach more than 60,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.

     

    Have we missed an important article or publication in Mesenchymal Cell News? Click here to submit!

    Comments or suggestions? Submit your feedback here

    Learn more about Mesenchymal Cell News: Archives | Events | Contact Us